Signal Transduction Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Signal Transduction stocks.

Signal Transduction Stocks Recent News

Date Stock Title
Nov 1 VSTM Verastem Oncology submits NDA for ovarian cancer treatment
Nov 1 DAWN We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Easily Afford To Drive Business Growth
Nov 1 BTMD Wall Street Analysts See an 88.04% Upside in biote Corp. (BTMD): Can the Stock Really Move This High?
Nov 1 VSTM Verastem Oncology completes rolling NDA submission to FDA for ovarian cancer treatment
Oct 31 VSTM Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
Oct 31 GPCR Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
Oct 31 VSTM Verastem Oncology to Participate in Upcoming Investor Conferences
Oct 31 DAWN Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Oct 31 DAWN Day One Biopharmaceuticals, Inc. (DAWN) Q3 2024 Earnings Call Transcript
Oct 30 DAWN Day One Biopharmaceuticals, Inc. (DAWN) Surpasses Q3 Earnings and Revenue Estimates
Oct 30 DAWN Day One Biopharmaceuticals reports Q3 results
Oct 30 RVMD Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024
Oct 30 DAWN Day One Reports Third Quarter 2024 Financial Results and Corporate Progress
Oct 29 BTMD Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call
Oct 28 PBYI 3 US Penny Stocks With Market Caps Under $700M
Oct 28 BTMD Is biote Corp. (BTMD) a Great Value Stock Right Now?
Oct 27 TECX Tectonic Therapeutic Independent Director Acquires 7.0% More Stock
Signal Transduction

Signal transduction is the process by which a chemical or physical signal is transmitted through a cell as a series of molecular events, most commonly protein phosphorylation catalyzed by protein kinases, which ultimately results in a cellular response. Proteins responsible for detecting stimuli are generally termed receptors, although in some cases the term sensor is used. The changes elicited by ligand binding (or signal sensing) in a receptor give rise to a signaling cascade, which is a chain of biochemical events along a signaling pathway. When signaling pathways interact with one another they form networks, which allow cellular responses to be coordinated, often by combinatorial signaling events. At the molecular level, such responses include changes in the transcription or translation of genes, and post-translational and conformational changes in proteins, as well as changes in their location. These molecular events are the basic mechanisms controlling cell growth, proliferation, metabolism and many other processes. In multicellular organisms, signal transduction pathways have evolved to regulate cell communication in a wide variety of ways.
Each component (or node) of a signaling pathway is classified according to the role it plays with respect to the initial stimulus. Ligands are termed first messengers, while receptors are the signal transducers, which then activate primary effectors. Such effectors are often linked to second messengers, which can activate secondary effectors, and so on. Depending on the efficiency of the nodes, a signal can be amplified (a concept known as signal gain), so that one signaling molecule can generate a response involving hundreds to millions of molecules. As with other signals, the transduction of biological signals is characterised by delay, noise, signal feedback and feedforward and interference, which can range from negligible to pathological. With the advent of computational biology, the analysis of signaling pathways and networks has become an essential tool to understand cellular functions and disease, including signaling rewiring mechanisms underlying responses to acquired drug resistance.

Browse All Tags